Mark W. Kieran, MD, PhD
Director, Pediatric Medical Neuro-Oncology
Associate Professor of Pediatrics, Harvard Medical School
Neuro-oncology, Experimental therapies, Anti-angiogenesis, Phase 1/Phase 2 trials
Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA 02215
Pediatric Hematology/Oncology, 1996, 2003, 2013
Boston Children's Hospital/Dana-Farber Cancer Institute, Pediatric Hematology/Oncology
Montreal Children's Hospital, McGill University
University of Calgary Faculty of Medicine
Dr. Kieran received his PhD in 1983 from the University of Alberta, Edmonton, Canada, and his MD in 1986 from the University of Calgary. He completed postgraduate training in molecular biology at the Pasteur Institute in Paris. After a pediatric residency in Montreal at McGill University, he received postdoctoral education at Boston Children’s Hospital (BCH). In 1998, he became director of Pediatric Medical Neuro-Oncology at Dana-Farber/Boston Children’s. In addition to his role in the treatment of patients with brain tumors and the development of novel agents for the treatment of recurrent tumors, he continues to focus his laboratory efforts on angiogenesis agents from work he started in the laboratory of the late Dr. Judah Folkman.
Video: Meet Mark W. Kieran
Mark Kieran, MD, PhD, explains how the multidisciplinary team of specialists at Dana-Farber/Boston Children's come together to deliver specialized care for each child.
Mark Kieran, MD, PhD, describes different types of brain tumors in children and how we treat them.